Short Term Outcomes From Minimally Invasive Surgery for the Treatment of Atrial Fibrillation

The purpose of this study is to assess the efficacy of minimally invasive surgery for atrial fibrillation.

Completed

Looking for future studies?

Key information

Conditions

Atrial Fibrillation Arrhythmias, Cardiac Cardiovascular Diseases Heart Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Division of Cardiology Virginia Commonwealth University

Richmond, Virginia, 23298, United States

About this study

Patients who are undergoing or who have undergone minimally invasive surgery for atrial fibrillation will be followed prospectively. At 6 to 9 months, 1 and two years post surgery follow-up subjects will receive a trans-telephonic monitor to wear for approximately 1 month, and will submit transmissions on a daily basis. Episodes of atrial fibrillation will be documented during this time. The overall efficacy of the procedure will be assessed based on the freedom from atrial fibrillation at the time of transtelephonic monitoring.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

18 or older
paroxysmal, persistent, or permanent atrial fibrillation

Exclusion criteria

concomitant heart surgery requiring open thoracotomy

Treatment and study plan

Primary outcomes

Transtelephonic monitoring for the identification of post surgical Atrial Fibrillation

Time frame: six months and 1 year

Sponsors and collaborators

Lead sponsor

Virginia Commonwealth University

Other

Registry information

Official study title

Prospective Analysis of the Wolf Minimaze Procedure for Treatment of Atrial Fibrillation

Important dates

Study start: 2007
Primary completion: 2012
Study completion: 2012
First posted: Dec 12, 2007
Registry last updated: Apr 14, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed